[{"id":"1f0aec53-2934-4132-a061-58ff65518298","acronym":"","url":"https://clinicaltrials.gov/study/NCT06984588","created_at":"2025-09-07T01:41:15.296Z","updated_at":"2025-09-07T01:41:15.296Z","phase":"Phase 2/3","brief_title":"A Study to Compare Uliledlimab Combined With Toripalimab, Toripalimab Monotherapy, and Pembrolizumab Monotherapy in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic PD-L1- and CD73- Selected Non-Small Cell Lung Cancer","source_id_and_acronym":"NCT06984588","lead_sponsor":"TJ Biopharma Co., Ltd.","biomarkers":" PD-L1 • BRAF","pipe":"","alterations":" ","tags":["PD-L1 • BRAF"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Keytruda (pembrolizumab) • Loqtorzi (toripalimab-tpzi) • uliledlimab (TJD5)"],"overall_status":"Recruiting","enrollment":" Enrollment 450","initiation":"Initiation: 03/28/2024","start_date":" 03/28/2024","primary_txt":" Primary completion: 08/05/2028","primary_completion_date":" 08/05/2028","study_txt":" Completion: 09/30/2028","study_completion_date":" 09/30/2028","last_update_posted":"2025-05-22"},{"id":"f7269564-444d-4c70-92c1-a166c7275795","acronym":"","url":"https://clinicaltrials.gov/study/NCT05001347","created_at":"2021-08-11T14:55:41.650Z","updated_at":"2024-07-02T16:35:33.668Z","phase":"Phase 2","brief_title":"A Clinical Study of TJ004309 With Atezolizumab (TECENTRIQ®) in Patients With Ovarian Cancer and Selected Solid Tumors","source_id_and_acronym":"NCT05001347","lead_sponsor":"I-Mab Biopharma US Limited","biomarkers":" HER-2 • PD-L1 • ER • PGR","pipe":" | ","alterations":" PD-L1 expression • HER-2 negative • ER negative • PGR negative","tags":["HER-2 • PD-L1 • ER • PGR"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e PD-L1 expression • HER-2 negative • ER negative • PGR negative"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Tecentriq (atezolizumab) • uliledlimab (TJD5)"],"overall_status":"Completed","enrollment":" Enrollment 25","initiation":"Initiation: 11/02/2021","start_date":" 11/02/2021","primary_txt":" Primary completion: 02/08/2023","primary_completion_date":" 02/08/2023","study_txt":" Completion: 02/08/2023","study_completion_date":" 02/08/2023","last_update_posted":"2023-10-12"}]